REACTIVO Y CONTROLES PARA LA DETERMINACIÓN CUANTITATIVA DE HEMOGLOBINA GLICADA EN MUESTRAS DE SANGRE TOTAL
Mexico·Clase I·III. Agentes de
diagnóstico·CORPORINTER, S.A. DE C.V.·Registered April 23, 2024- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- HBA1C-CHECK-1.
- Trade Name (English)
- HBA1C-CHECK-1.
- Analysis ID
- 1168R2024 SSA
- Registration Date
- April 23, 2024
- Name (Spanish)
- CORPORINTER, S.A. DE C.V.
- Name (English)
- CORPORINTER, S.A. DE C.V.
Access comprehensive regulatory information for REACTIVO Y CONTROLES PARA LA DETERMINACIÓN CUANTITATIVA DE HEMOGLOBINA GLICADA EN MUESTRAS DE SANGRE TOTAL (REACTIVO Y CONTROLES PARA LA DETERMINACIÓN CUANTITATIVA DE HEMOGLOBINA GLICADA EN MUESTRAS DE SANGRE TOTAL) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1168R2024 SSA and manufactured by CORPORINTER, S.A. DE C.V.. The device was registered on April 23, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.